Cargando…
TGF-β Mediated Immune Evasion in Cancer—Spotlight on Cancer-Associated Fibroblasts
SIMPLE SUMMARY: The different components surrounding a tumor are collectively known as the tumor microenvironment (TME). The transforming growth factor-beta (TGF-β) signaling pathway is activated in the TME and the tumor, leading to alteration in the composition of the TME that favors tumor growth a...
Autores principales: | Ghahremanifard, Parisa, Chanda, Ayan, Bonni, Shirin, Bose, Pinaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762018/ https://www.ncbi.nlm.nih.gov/pubmed/33291370 http://dx.doi.org/10.3390/cancers12123650 |
Ejemplares similares
-
The SUMO System and TGFβ Signaling Interplay in Regulation of Epithelial-Mesenchymal Transition: Implications for Cancer Progression
por: Chanda, Ayan, et al.
Publicado: (2018) -
TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure
por: Chakravarthy, Ankur, et al.
Publicado: (2018) -
Recombinant human PRG4 (rhPRG4) suppresses breast cancer cell invasion by inhibiting TGFβ-Hyaluronan-CD44 signalling pathway
por: Sarkar, Anusi, et al.
Publicado: (2019) -
Sumoylated SnoN interacts with HDAC1 and p300/CBP to regulate EMT-associated phenotypes in mammary organoids
por: Chanda, Ayan, et al.
Publicado: (2023) -
The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness
por: Chandhoke, Amrita Singh, et al.
Publicado: (2017)